Anti-CD38 Antibody Treating APS With Thrombocytopenia

Abroad (travel likely)RecruitingPHASE2

Conditions

Antiphospholipid Syndrome · Thrombocytopenia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Chinese Academy of Medical Science and Blood Disease Hospital, Tianjin, Tianjin Municipality, China
Contact: Study coordinator (Yunfei Chen, MD) · chenyunfei@ihcams.ac.cn · +86-22-23909009

Study leads

Lei Zhang, MD
Principal Investigator
Chinese Academy of Medical Science and Blood Disease Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia

Antiphospholipid Syndrome · Thrombocytopenia · Treatment

Abroad (travel likely)RecruitingPHASE2

Tianjin, China · Tianjin, China

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

Antiphospholipid Syndrome (APS) · Bullous Pemphigoid (BP) · Behçet's Syndrome (BS)

Abroad (travel likely)RecruitingPHASE1

Orange, United States · Baltimore, United States

Anifrolumab in Adults With Primary Antiphospholipid Syndrome (AnifAPS Trial)

Antiphospholipid Syndrome (APS)

Abroad (travel likely)RecruitingPHASE2

Athens, Greece

IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy

High Risk Pregnancy · Pregnancy Complications · Antiphospholipid Syndrome in Pregnancy

Abroad (travel likely)RecruitingPHASE2

New York, United States · Salt Lake City, United States